Latest News From "The Pink Sheet" DAILY - Teva Wins Ratiopharm

Teva Wins Ratiopharm For $5 Billion, And Gains A Key Foothold In Europe

The acquisition makes Teva the leading generics company in Europe, which is a key to its ambitious plans for global growth.   read more

 

Somaxon's Silenor Gains An FDA Approval, But Can The Pharma Afford A Launch?

Somaxon hopes to launch its insomnia drug in the second half of 2010, but is still searching for a U.S. commercial partner.   read more

 

Pharma Market-Share Fees In House Health Care Reform Package Less Than Expected

Brand drug manufacturers will pay annually increasing fees until 2019, totaling $28 billion over 10 years, after which the figure drops and holds steady.   read more

 

With One Foot Firmly Planted In Oncology, Roche Moves The Other Into CV/Metabolic

The Swiss drug maker, long a leader in oncology, is vying to become a frontrunner in treating cardiovascular disease and metabolic disorders.   read more

 

NIH Genetic Testing Registry Aims To Shed Light Where Oversight Has Been Patchy

Voluntary registry falls short of the mandatory registration sought by advocates, HHS advisors and members of Congress.   read more

 

The Environmental Cost Of Production: Will Big Pharma Be On The Hook For API Hazards?

India's high-publicity environmental problems may spur a consumer-driven push for environmentally certified pharmaceuticals.   read more

 

Viagra V. Cialis: Pfizer Ends Its Patent Battle Against Lilly

Pfizer drops its suit a month after PTO's appeals board rules its patent claim is anticipated by use of a Chinese herb to treat impotence.   read more